🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Atazanavir, ritonavir, lamivudine

Found 52 matching trials

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

PHASE4

The goal of this clinical study is to provide continued access to the study...

Status

Recruiting

Location

Helios Salud

Start Date

2024-08-27

Trial ID

NCT06337032

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

PHASE3

The primary objective of this study in antiretroviral (ARV)-naïve Human imm...

Status

Terminated

Location

Multiple Locations

Start Date

2012-07-31

Trial ID

NCT01620944

Treatments Being Tested

Atazanavir Ritonavir Lamivudine Tenofovir/Emtricitabine

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

PHASE3

The primary objective of this study is to evaluate the efficacy of switchin...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2018-08-28

Trial ID

NCT03631732

Treatments Being Tested

B/F/TAF NRTIs Third Agent

MARCH Central Nervous System Substudy

N/A

This substudy is a prospective, observational, open-label, randomised study...

Status

Completed

Location

Fundación IDEAA

Start Date

2012-06

Trial ID

NCT01637233

Treatments Being Tested

Arm 1 TNucleotide Analogue Reverse Transcriptase Inhibitors and Boosted Protease Inhibitors Arm 2 Maraviroc and Protease Inhibitors Arm 3 Maraviroc and Nucleotide Analogue Reverse Transcriptase Inhibitors

Sex, Aging and Antiretroviral Pharmacokinetics

N/A

The purpose of this research study is to learn about levels of antiretrovir...

Status

Completed

Location

The University of North Carolina at Chapel Hill

Start Date

2008-03

Trial ID

NCT00666055

Treatments Being Tested

ARV regimen chosen by treating physician

Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults

PHASE4

The primary objective of this study is to assess glomerular function before...

Status

Completed

Location

Multiple Locations

Start Date

2014-12-15

Trial ID

NCT02246998

Treatments Being Tested

STB TVD ATR RTV ATV ABC/3TC Iohexol

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

PHASE3

This study was designed to test the efficacy, safety, tolerability and dura...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-03

Trial ID

NCT00440947

Treatments Being Tested

Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r)Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

PHASE3

The purpose of this randomized, open-label, multicenter, active-controlled ...

Status

Completed

Location

University of Alabama - Birmingham

Start Date

2010-11

Trial ID

NCT01252940

Treatments Being Tested

FTC/RPV/TDF PI RTV NRTIs

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

PHASE3

This study is designed to demonstrate the non-inferior antiviral activity o...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-08-22

Trial ID

NCT01910402

Treatments Being Tested

Dolutegravir/abacavir/lamivudine FDC Atazanavir Ritonavir Tenofovir/emtricitabine FDC

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

PHASE2

The goal of this clinical study is to learn more about the safety and dosin...

Status

Active Not Recruiting

Location

Pediatric Infectious Disease Associates

Start Date

2014-01-16

Trial ID

NCT02016924

Treatments Being Tested

ATV DRV Cobicistat BR F/TAF LPV/r Third Unboosted Drug Cobicistat TOS F/TAF TOS

Previous Next